Prognostic value of circulating tumour DNA fraction in metastatic castration-resistant prostate cancer: Insights from the ProBio trial

被引：0
|
作者：
Crippa, A. [1 ]
Mortezavi, A. [2 ]
Discacciati, A. [1 ]
Karlsson, C. T. [3 ]
Strijbos, M. H. [4 ]
Janes, E. [5 ]
Enblad, G. [6 ]
Sautois, B. [7 ]
Ullen, A. [8 ]
Stenner-Liewen, F. [9 ]
Hjalm-Eriksson, M. E. [10 ]
De Maeseneer, D. J. [11 ]
Schatteman, P. [12 ]
Ghysel, C. [13 ]
Oldenburg, J. [14 ]
Lindberg, J. [15 ]
Ost, P. [16 ]
Eklund, M. [17 ]
Gronberg, H. [15 ]
De Laere, B. [18 ]
机构：
[1] Karolinska Inst, Med Epidemiol & Biostat, Stockholm, Sweden
[2] Univ Hosp Basel, Dept Urol, Basel, Switzerland
[3] Umea Univ, Radiat Sci, Oncol, Umea, Sweden
[4] GZA Ziekenhuizen, Med Oncol Dept, Campus Sint Augustinus, Antwerp, Belgium
[5] Sundsvall Hosp, Dept Oncol, Sundsvall, Sweden
[6] Akad Sjukhuset Uppsala, Oncol Dept, Uppsala, Sweden
[7] Ctr Hosp Univ Sart Tilman, Dept Med Oncol, Liege, Belgium
[8] Karolinska Inst, Dept Oncol, Stockholm, Sweden
[9] Univ Spital Basel, Oncol Dept, Basel, Switzerland
[10] Capio St Gorans Hosp, Surg Dept, Stockholm, Sweden
[11] AZ Sint Lucas, Dept Med Oncol, Brugge, Belgium
[12] Onze Lieve Vrouw Clin, Urol, Campus Aalst, Aalst, Belgium
[13] AZ Sint Jan Brugge Oostende AV, Dept Urol, Brugge, Belgium
[14] Univ Oslo, Dept Oncol, Oslo, Norway
[15] Karolinska Inst, Med Epidemiol & Biostat, Stockholm, Sweden
[16] Univ Hosp Ghent, UZ Gent, Radiat Oncol, Ghent, Belgium
[17] Karolinska Inst, Med Epidemiol & Biostat, Huddinge, Sweden
[18] Karolinska Inst, Inst Med Epidemiol & Biostat, Med Epidemiol & Biostat, Solna, Sweden
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1704
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1623P
引用
收藏
页码：S980 / S980
页数：1
相关论文
共 50 条
  • [31] Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
    Scher, Howard I.
    Jia, Xiaoyu
    de Bono, Johann S.
    Fleisher, Martin
    Pienta, Kenneth J.
    Raghavan, Derek
    Heller, Glenn
    LANCET ONCOLOGY, 2009, 10 (03): : 233 - 239
  • [32] Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
    Tolmeijer, Sofie H.
    Boerrigter, Emmy
    Sumiyoshi, Takayuki
    Kwan, Edmond M.
    Ng, Sarah W. S.
    Annala, Matti
    Donnellan, Grainne
    Herberts, Cameron
    Benoist, Guillemette E.
    Hamberg, Paul
    Somford, Diederik M.
    van Oort, Inge M.
    Schalken, Jack A.
    Mehra, Niven
    van Erp, Nielka P.
    Wyatt, Alexander W.
    CLINICAL CANCER RESEARCH, 2023, 29 (15) : 2835 - 2844
  • [33] Inflammatory markers as prognostic factors in metastatic castration-resistant prostate cancer
    Donate-Moreno, M. J.
    Lorenzo-Sanchez, M., V
    De Mera-Sanchez Migallon, I. Diaz
    Herraiz-Raya, L.
    Esper-Rueda, J. A.
    Legido-Gomez, O.
    Rico-Marco, S.
    Salinas-Sanchez, A. S.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (10): : 692 - 700
  • [34] New insights for drug resistance in metastatic castration-resistant prostate cancer
    Kushwaha, Prem Prakash
    Gupta, Sanjay
    CANCER DRUG RESISTANCE, 2022, 5 (03) : 846 - 849
  • [35] Circulating Tumour Cells as Surrogate Biomarkers in Castration-Resistant Prostate Cancer Trials
    Bjartell, Anders
    EUROPEAN UROLOGY, 2011, 60 (05) : 905 - 907
  • [36] Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand
    Lojanapiwat, Bannakij
    Pripatnanont, Choosak
    Choonhaklai, Vorapot
    Soontornpun, Surithorn
    Sriplakich, Supon
    Leewansangtong, Sunai
    Santi-ngamkun, Apirak
    Opanuraks, Julin
    Kongcharoensombat, Wisoot
    Na-Songkla, Bhapapak
    Raksakul, Wiroj
    Predanon, Chagkrapan
    PROSTATE INTERNATIONAL, 2017, 5 (01) : 1 - 7
  • [37] Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1174 - 1175
  • [38] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [39] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [40] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    de Bono, J.
    Mateo, J.
    Fizazi, K.
    Saad, F.
    Shore, N.
    Sandhu, S.
    Chi, K. N.
    Sartor, O.
    Agarwal, N.
    Olmos, D.
    Thiery-Vuillemin, A.
    Twardowski, P.
    Mehra, N.
    Goessl, C.
    Kang, J.
    Burgents, J.
    Wu, W.
    Kohlmann, A.
    Adelman, C. A.
    Hussain, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2091 - 2102
12345